Abstract
The in vitro oxidation of hexobarbital by rat liver microsomes yields 3-hydroxyhexobarbital as the prime product. Therefore, the presently described method was developed to assay 3-OH-Hex.2 The assay involves the incubation of 2-14C-hexobarbital with rat liver microsomes, in the presence of an NADPH-generating system, at 37°C in an atmosphere of air. To terminate the reaction, 1 M citrate buffer, pH 5.5 (containing 15% NaCl), is added and the unmetabolized hexobarbital is extracted with 1-chlorobutane. The 3-OH-Hex in the aqueous phase is then extracted with ethyl acetate and an aliquot of the EtOAc is evaporated and counted in a scintillation spectrometer. Thin-layer chromatography demonstrated that the BuCl phase contained almost exclusively the unmetabolized hexobarbital, whereas the EtOAc contained 3-OH-Hex and occasionally a small amount of 3-ketohexobarbital. The simplicity of the assay permits a large number of determinations in a given time. The high sensitivity of the assay allows determinations when a small amount of the product, 3-OH-Hex (corresponding to conversion of less than 1% of hexobarbital) is formed; namely, when initial reaction rates are measured and when a small amount of tissue is available.
Footnotes
- Received May 26, 1973.
- Copyright © 1973 by The American Society for Pharmacology and Experimental Therapeutics
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|